Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol
1993; 2: 335–40.CrossRefPubMed
Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg
1994; 220: 391–401.PubMed
Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA
1996; 276: 1818–22.CrossRefPubMed
Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997; 80: 1188–97.
Singletary SE. Systemic treatment after sentinel lymph node biopsy in breast cancer: who, what and why? J Am Coll Surg 2001; 192: 220–30.
Sobin LH, Wittekind C, eds. TNM: Classification of Malignant Tumors. 6th ed. New York: Wiley-Liss, 2002.
van Diest PJ, Torrenga H, Borgstein PJ, et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology
1999; 35: 14–8.CrossRefPubMed
Smidt ML, Besseling R, Wauters CA, Strobbe LJ. Intraoperative scrape cytology of the sentinel lymph node in patients with breast cancer. Br J Surg 2002; 89: 1290–3.
Salem AA, Douglas-Jones AG, Sweetland HM, Mansel RE. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry: I. Protocol of rapid immunostaining of touch imprints. Eur J Surg Oncol 2003; 29: 25–8.
Nahrig JM, Richter T, Kuhn W, et al. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry. Breast J 2003; 9: 277–81.
Veronesi U, Zurrida S, Mazzarol G, Viale G. Extensive frozen section examination of axillary sentinel nodes to determine selective axillary dissection. World J Surg 2001; 25: 806–8.
Hill ADK, Tran KN, Akhurst T, Yeung T, Yeh SDJ, Rosen PP. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999; 229: 528–35.
Zurrida S, Mazzarol G, Galimberti V, et al. The problem of the accuracy of intraoperative examination of axillary sentinel nodes in breast cancer. Ann Surg Oncol 2001; 8: 817–20.
Weiser MR, Montgomery LL, Susnik B, Tan LK, Borgen PI, Cody HS. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile? Ann Surg Oncol 2000; 45: 185–90.
Chao C, Wong SL, Ackermann D, et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am J Surg 2001; 182: 609–15.
Tanis PJ, Boom RPA, Koops HS, et al. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol
2001; 8: 222–6.CrossRefPubMed
Gulec SA, Su J, O’Leary JP, Stolier A. Clinical utility of frozen section in sentinel node biopsy in breast cancer. Am Surg 2001; 67: 529–32.
Ratanawichitrasin A, Biscotti CV, Levy L, Crowe JP. Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer. Br J Surg 1999; 86: 1346–8.
Lee A, Krishnamurthy S, Sahin A, Symmans WF, Hunt K, Sneige N. Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients. Cancer 2002; 96: 225–31.
Llatjos M, Castella E, Fraile M, et al. Intraoperative assessment of sentinel lymph nodes in patients with breast carcinoma: accuracy of rapid imprint cytology compared with definitive histologic workup. Cancer 2002; 96: 150–6.
Henry-Tillman RS, Korourian S, Rubio IT, et al. Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience Ann Surg Oncol 2002; 9: 333–9.
Kane JM III, Edge SB, Winston JS, Watroba N, Hurd TC. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann Surg Oncol 2001; 8: 361–7.
Cserni G. The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients. Am Surg 2001; 67: 86–91.
Lambah PA, McIntyre MA, Chetty U, Dixon JM. Imprint cytology of axillary lymph nodes as an intraoperative diagnostic tool. Eur J Surg Oncol 2003; 29: 224–8.
Menes TS, Tartter PI, Mizrachi H, Smith SR, Estabrook A. Touch preparation or frozen section for intraoperative detection of sentinel lymph node metastases from breast cancer. Ann Surg Oncol 2004; 20: 1166–70.
Shiver SA, Creager AJ, Geisinger K, Terrier ND, Shen P, Levine EA. Intraoperative analysis of sentinel lymph nodes by imprint cytology for cancer of the breast. Am J Surg 2002; 184: 424–7.
Karamlou T, Johnson NM, Chan B, Franzini D, Mahin D. Accuracy of intraoperative touch imprint cytologic analysis of sentinel lymph nodes in breast cancer. Am J Surg 2003; 185: 425–8.
Mullenix PS, Carter PL, Martin MJ, et al. Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer. Am J Surg 2003; 185: 420–4.
Creager AJ, Geisinger KR, Shiver SA, et al. Intraoperative evaluation of sentinel lymph nodes for metastatic breast carcinoma by imprint cytology. Mod Pathol 2002; 15: 1140–7.
Scognamiglio T, Hoda RS, Edgar MA, Hoda SA. The need for vigilance in the pathologic evaluation of sentinel lymph nodes: a report of two illustrative cases. Breast J 2003; 9: 420–2.
Wilke LG, Giuliano A. Sentinel lymph node biopsy in patients with early-stage breast cancer: status of the National Clinical Trials. Surg Clin North Am 2003; 83: 901–10.
Grube BJ, Giuliano AE. Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol
2001; 20: 230–7.CrossRefPubMed
Harlow SP, Krag DN. Sentinel lymph node—why study it? Implications of the B-32 study. Semin Surg Oncol 2001; 20: 224–9.
Berry N, Jones DB, Marshall R, et al. Comparison of the detection of breast carcinoma metastases by routine histological diagnosis and by immunohistochemical staining. Eur Surg Res 1988; 20: 225–32.
Bussolati G, Gugliotta P, Morra I, Pietribiasi F, Berardengo E. The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Br J Surg 1986; 54: 631–6.
Canavese G, Gipponi M, Catturich A, et al. Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients. J Surg Oncol 2001; 77: 81–8.
Mignotte H, Treilleux I, Faure C, Nessah K, Bremond A. Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur J Surg Oncol 2002; 28: 623–6.
Turner RR, Chu KU, Qi K, et al. Pathologic features associated with non sentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89: 574–81.
Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchil A, Giuliano AE. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999; 229: 536–41.
Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001; 15: 1378–84.
Kamath VJ, Giuliano R, Dauway EL, et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 2001; 136: 688–92.
De Mascarel I, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with larger follow-up. Br J Cancer 1992; 66: 523–7.
Hainsworth PI, Tjandra JJ, Stillwell RG, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Cancer 1993; 80: 459–63.
International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 1990; 335: 1565–8.
Van Zee KJ, Manasseh DME, Bevilacqua JLB, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2004; 10: 1140–1151.
Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg
1998; 186: 275–83.CrossRefPubMed
Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med
1998; 339: 941–5.CrossRefPubMed
Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345–50.
Haigh PI, Hansen NM, Qi K, Giuliano AE. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 2000; 7: 21–7.
Villa G, Gipponi M, Buffoni F, et al. Localization of the sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue dye and intraoperative gamma probe. Tumori 2000; 86: 297–9.